Koi Research Labs Expands It's Distribution in USA & Canada
Koi Research Labs expands research-grade peptide distribution across the USA and Canada with COA-verified, in-country fulfillment. Research use only.
WYOMING, WY, WY, UNITED STATES, June 8, 2026 /EINPresswire.com/ -- Koi Research Labs has expanded research peptide distribution across the USA and Canada through separate in-country fulfillment operations in each market, giving researchers in both countries faster domestic delivery and Certificate of Analysis (COA) verified inventory. All compounds remain research-use-only (RUO) material, not for human use, and are not approved by the U.S. Food and Drug Administration or Health Canada for therapeutic use.Koi Research Labs Expands Research Peptide Distribution in the USA and Canada
The expansion adds in-country fulfillment and domestic distribution in both markets, with cold-chain handling where required and per-batch Certificate of Analysis documentation. Researchers ordering research peptides in the USA receive shipments through the U.S. fulfillment network. Researchers ordering research peptides in Canada receive shipments through the Canadian fulfillment network. Material does not cross the U.S.-Canada border in either direction.
The structure is two parallel domestic operations rather than a cross-border distribution model. Both operations release inventory to the same analytical standard. Every lot of research-grade peptides shipped in either market is HPLC purity verified, mass spectrometry (MS) identity confirmed, and accompanied by a lot-specific COA tied to the synthesis batch number printed on each vial. Lyophilized material ships in moisture-barrier packaging with cold-chain handling where stability profiles require it.
“In-country distribution gives researchers in the United States and Canada faster, more reliable access to research-grade peptides with the analytical documentation laboratories need,” said Dr Tshering Pedon, research contributor at Koi Research Labs. “The model is two parallel domestic operations, not cross-border shipping. The QC standard is identical across both.”
Buying Research Peptides Domestically in the USA and Canada
Researchers planning to buy peptides USA receive shipments through the U.S. fulfillment network. Those looking to buy peptides Canada receive shipments through the Canadian fulfillment network. Domestic peptide shipping in each market reduces transit time and removes the cross-border customs handling that international peptide sourcing typically involves.
Fast peptide delivery within each country is typically 2 to 5 business days, depending on the destination and shipping option selected. International peptide sourcing can extend transit windows significantly and introduce customs detention risk. The U.S. Customs and Border Protection (CBP) and the Canada Border Services Agency (CBSA) both screen unapproved peptide shipments at their respective borders. Material held at customs is also exposed to ambient temperature for longer periods, which matters for lyophilized peptide stability, even though lyophilized material tolerates ambient transit better than reconstituted material.
Shorter domestic transit is the operational benefit. Analytical documentation is the same across both markets.
Research-Use-Only Status in the USA and Canada
All compounds supplied by Koi Research Labs are research-use-only material. They are not approved for human use by the U.S. Food and Drug Administration or Health Canada, are not dietary supplements or natural health products, and carry no Drug Identification Number (DIN) in Canada. Research peptides in both the USA and Canada operate under research-supply frameworks distinct from approved drug pathways.
Expanded distribution improves logistics. It does not change the regulatory status of research-use-only materials and does not remove obligations under the Federal Food, Drug, and Cosmetic Act (FD&C Act) in the United States or the Food and Drugs Act in Canada. An RUO label is not an import exemption or a use exemption in either country.
About Koi Research Labs
Koi Research Labs is a research peptide supplier serving qualified researchers in the United States and Canada. The company supplies a catalog of lyophilized research peptides released under HPLC purity verification, mass spectrometry identity confirmation, and bacterial endotoxin testing, with lot-specific Certificates of Analysis tied to the synthesis batch printed on each vial.
All products supplied by Koi Research Labs are intended strictly for laboratory and research use only. They are not for human or animal consumption, are not dietary supplements or natural health products, and are not approved by the U.S. Food and Drug Administration or Health Canada for therapeutic use. Products do not carry a DIN in Canada. Expanded distribution improves transit logistics and does not alter the regulatory status of research-use-only materials. Nothing in this release constitutes medical advice.
Media Contact
Koi Research Labs
Email: press@koipeptides.com
Website (USA): https://koipeptides.com
Website (Canada): https://koipeptidescanada.com
Disclaimer: Products referenced in this release are research-use-only material, not for human or animal consumption, and are not approved by the FDA or Health Canada. Expanded distribution is a logistics capability, not a compliance exemption. Nothing in this release constitutes medical advice.
Koi Peptides Team
Koi Research Labs
+1 850-790-9026
press@koipeptides.com
Visit us on social media:
LinkedIn
Instagram
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
